Literature DB >> 6470573

Incidence of Menière's disease.

B C Okafor.   

Abstract

A study of the incidence of Menière's disease in the otolaryngological population of a black community is presented. 34 patients out of a total attendance of 8,550 had proven Menière's disease, according to defined criteria, giving an incidence of 0.4 per cent. This compares favourably with the incidence in other racial groups but a peculiarly high proportion of female patients is noted. Some of the reasons for the apparent rarity of the disease in negroes are discussed and it is suggested that improved facilities may in future show that Menière's disease is no more rare in negroes than in other racial groups.

Entities:  

Mesh:

Year:  1984        PMID: 6470573     DOI: 10.1017/s0022215100147449

Source DB:  PubMed          Journal:  J Laryngol Otol        ISSN: 0022-2151            Impact factor:   1.469


  5 in total

1.  Meniere's disease: rare or underdiagnosed among Africans.

Authors:  T S Ibekwe; G T A Ijaduola
Journal:  Eur Arch Otorhinolaryngol       Date:  2007-07-04       Impact factor: 2.503

Review 2.  Is allergy related to Meniere's disease?

Authors:  Catherine Banks; Samuel McGinness; Richard Harvey; Raymond Sacks
Journal:  Curr Allergy Asthma Rep       Date:  2012-06       Impact factor: 4.806

3.  Vestibular disorders among adults in a tertiary hospital in Lagos, Nigeria.

Authors:  O A Somefun; O S Giwa; B A Bamgboye; I Irene Okeke-Igbokwe; A A Abdul Azeez
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-05-13       Impact factor: 2.503

Review 4.  Towards personalized medicine in Ménière's disease.

Authors:  Jose Antonio Lopez-Escamez; Angel Batuecas-Caletrio; Alexandre Bisdorff
Journal:  F1000Res       Date:  2018-08-15

5.  Integrative genomic expression analysis reveals stable differences between lung cancer and systemic sclerosis.

Authors:  Heng Li; Liping Ding; Xiaoping Hong; Yulan Chen; Rui Liao; Tingting Wang; Shuhui Meng; Zhenyou Jiang; Dongzhou Liu
Journal:  BMC Cancer       Date:  2021-03-10       Impact factor: 4.430

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.